This dashboard summarizes outcomes for 3,728 patients tracked across JLC’s State Funded Initiatives, representing 115,229 clinical scale assessments and 11,220 EEG recordings. Most patients sought care for sleep disorders, depression, anxiety, and PTSD, with sleep issues being the most common concern. The data focuses on patients who began treatment after initial assessment and completed their scheduled scales, allowing for meaningful tracking of change over time.

Overall, patients experienced large and consistent improvements across every measured area. On average, symptoms of anxiety, PTSD, depression, and insomnia — along with opioid and alcohol cravings — decreased by roughly 50–65%, meaning most patients cut their symptom severity by about half or more. Taken together, the results suggest that patients not only felt better, but experienced clinically meaningful improvements across multiple aspects of mental and neurological health.